What Is a Tanner Stage? Puberty’s 5 Stages Defined

Tanner Stages are a medical tool doctors use to track puberty’s five phases of physical development in both girls and boys.

Tanner stages are a five-point scale that doctors use to track how far a child or adolescent has progressed through puberty. Developed from a longitudinal growth study of children in London between 1949 and 1971, the system rates the development of breasts and pubic hair in girls, and genitalia and pubic hair in boys, from Stage 1 (no development) through Stage 5 (adult maturity). The scale remains the most widely used clinical tool for assessing sexual maturation, but it measures more than it appears to on the surface, and it comes with real limitations that even many clinicians underappreciate.

Where the Scale Came From

The Tanner stages are named after James M. Tanner, a British pediatric endocrinologist who, along with R.H. Whitehouse, conducted a groundbreaking longitudinal study of children’s growth in London from 1949 to 1971. By photographing and measuring children at regular intervals over years, Tanner mapped the sequence and timing of physical changes during puberty and distilled them into a reproducible rating system. The original publications appeared in the 1960s and early 1970s, and despite their age, the stages have not been fundamentally revised. You will sometimes see them called the “Sexual Maturity Rating” (SMR) scale, which is the same thing under a different name.

What Triggers Puberty in the First Place

Before the visible changes that Tanner stages describe, a hormonal cascade has to begin deep in the brain. Puberty starts when the hypothalamic-pituitary-gonadal axis, which was active in infancy but then went quiet for years, reactivates. A signaling molecule called kisspeptin stimulates neurons in the hypothalamus to begin releasing gonadotropin-releasing hormone (GnRH) in pulses. Those pulses trigger the pituitary gland to release luteinizing hormone, which in turn drives the ovaries or testes to produce sex steroids like estrogen and testosterone. The physical changes you can see and measure with Tanner stages are downstream results of that hormonal ramp-up. Hormone levels and visible development usually track together early on but can diverge later in puberty, which is one reason the staging system is imperfect.

The Five Stages in Girls

In girls, Tanner staging tracks two separate features: breast development (rated B1 through B5) and pubic hair (rated PH1 through PH5). They do not necessarily move in lockstep, so a girl might be B3 but PH2 at a given visit.

  • Stage 1: No breast tissue beyond the flat chest of childhood. No pubic hair.
  • Stage 2: A small mound of breast tissue appears beneath the areola, often called “breast budding.” Sparse, lightly pigmented hair appears along the labia. This is the clinical starting line of puberty.
  • Stage 3: Breast tissue and the areola enlarge further, and the breast begins to take a more rounded shape. Pubic hair becomes darker, coarser, and spreads over a wider area.
  • Stage 4: The areola and nipple form a secondary mound that projects above the breast contour. Pubic hair is adult in texture but covers a smaller area than in adults.
  • Stage 5: The breast reaches its adult shape, with the areola receding to the general contour of the breast. Pubic hair extends in an adult pattern.

The average age at which breast budding (Stage 2) begins varies by population. A large study of girls in Iran reported a median age of about 9.9 years for the onset of breast development and about 10.1 years for the onset of pubic hair. Menarche, a girl’s first menstrual period, typically arrives roughly two to two and a half years after breast budding, usually around Stage 3 or 4. The mean interval from breast Stage 2 to menarche is about 2.3 years, though the individual range is wide.

The Five Stages in Boys

In boys, the two features tracked are genital development (G1 through G5, focusing on the penis and scrotum) and pubic hair (PH1 through PH5). Testicular volume, measured with an orchidometer or ultrasound, often supplements the visual staging.

  • Stage 1: Testes, scrotum, and penis are the same size and proportion as in early childhood. No pubic hair.
  • Stage 2: The testes and scrotum enlarge, and the scrotal skin reddens and changes texture. Sparse hair appears at the base of the penis. Testicular volume reaching about 4 mL is often used as the threshold for puberty onset.
  • Stage 3: The penis begins to lengthen. The testes and scrotum continue to grow. Pubic hair becomes darker and curlier.
  • Stage 4: The penis grows in both length and breadth, and the glans develops. The scrotum darkens further. Pubic hair is adult-type but not yet fully spread.
  • Stage 5: Genitalia reach adult size and shape. Pubic hair extends to the inner thighs in the adult pattern.

Testicular volume increases in strong correlation with Tanner genital stages. One cross-sectional study of adolescent boys found a Spearman correlation of 0.943 between orchidometer-measured volume and genital stage. However, the study also flagged a limitation: among boys near the onset of puberty, about 16% were misclassified by visual Tanner staging alone compared to orchidometry, because the earliest genital changes can be subtle and hard to distinguish from prepubertal anatomy.

How the Staging Is Actually Done

In a clinical setting, a trained physician visually inspects and sometimes palpates the relevant anatomy and assigns a stage. For boys, a Prader orchidometer, which is a string of oval beads of known volumes, is held next to the testis for comparison. Ultrasound offers more precision but is not always practical in a routine visit. The Prader orchidometer tends to overestimate testicular volume compared to ultrasound, with discrepancies most pronounced at smaller volumes. Even so, all common measurement methods are highly reliable in terms of consistency between measurements.

Because physical examination can feel intrusive to adolescents, self-assessment has been studied extensively as an alternative. When adolescents rate their own development using pictures, accuracy is respectable but not perfect. A study found that about 84% of girls and 83% of boys agreed exactly with a physician’s pubic hair stage, while agreement on breast and genital development was somewhat lower. A meta-analysis concluded that agreement is moderate to substantial overall, and it improves when stages are grouped into broader categories like “pre-puberty,” “in puberty,” and “completing puberty” rather than pinpointing the exact stage. The use of realistic color images instead of traditional line drawings seems to help. One longitudinal study found near-perfect concordance between physician exams and self-assessments using color images at follow-up visits, though initial agreement for boys’ genital staging was weaker.

What Changes Beyond the Obvious

Tanner stages are defined by visible sex characteristics, but they track alongside sweeping changes in body composition, bone density, and even brain structure. As children progress through the stages, fat-free mass rises in both sexes, but the pattern splits. Boys in later stages gain proportionally more lean mass and bone mineral, while girls accumulate more body fat. By Stages 4 and 5, boys have significantly less body fat than girls at the same stage, and significantly more fat-free mass. Even within Stage 5, body composition continues to shift, especially in boys, where lean tissue keeps increasing with age independently of any further change in visible sexual maturation.

The body’s sensitivity to insulin also shifts during puberty. Research has shown that the direction of that change differs by sex and stage: girls at Stage 3 and boys at Stage 2 had notably more body fat than their counterparts at adjacent stages, and insulin sensitivity tracked closely with those body-composition changes. This is one reason pediatricians pay attention to Tanner staging even when puberty itself is not the concern: it provides context for metabolic lab values and growth projections.

Peak height velocity, the year of fastest growth, is another landmark that loosely maps to Tanner stage but with considerable individual variability. A study of contemporary U.S. youth found substantial variation in when peak height velocity occurred relative to a child’s rated Tanner stage, which is an important caveat for clinicians trying to predict adult height from pubertal staging alone.

Brain Development and Puberty Stage

Tanner stage is not just a body-surface measurement. It also correlates with changes in the brain, particularly in regions tied to emotion and social behavior. In girls, pubertal status has been significantly associated with the volume of the amygdala and hippocampus, structures involved in processing emotions and memory. Interestingly, age alone did not significantly predict these brain volumes once pubertal status was accounted for, suggesting that the hormonal changes of puberty, rather than simply getting older, drive at least some of the brain’s structural remodeling during adolescence. This finding has implications for understanding why emotional and behavioral changes in adolescence track more closely with physical maturation than with chronological age.

Why Puberty Is Starting Earlier

If your intuition says kids are developing younger than they used to, the data backs you up, at least partially. A meta-analysis of 30 studies found a significant decrease in the age at breast Stage 2 onset of about 0.24 years (roughly three months) per decade. Expert panels reviewing U.S. data from the 1940s through the 1990s also concluded there is sufficient evidence for a trend toward earlier breast development and earlier menarche in girls, though the evidence for other pubertal markers shifting earlier is weaker.

Childhood obesity is one of the strongest identified drivers. A large cohort study found that overweight and obese children reached pubertal milestones several months earlier than normal-weight peers: overweight girls hit milestones about 5.5 months earlier, and overweight boys about 3.1 months earlier. Central obesity, meaning fat concentrated around the waist, shows a particularly consistent association with earlier breast and pubic hair development in girls. In boys, the picture is slightly more complicated. One study found earlier puberty in overweight boys compared to normal-weight boys, but later puberty in obese boys compared to overweight boys, at least among white and African American boys. Hispanic boys showed no significant differences. The relationship in boys is clearly not as linear as in girls, and body fat seems to have a tipping point beyond which it may actually delay male puberty rather than accelerate it.

Environmental Chemicals and Pubertal Timing

Endocrine-disrupting chemicals (EDCs), synthetic compounds that can mimic or interfere with hormones, have been a focus of concern for decades. The evidence that they affect pubertal timing is suggestive but far from settled. Reviews have concluded that associations between EDC exposure and altered pubertal timing exist, but human epidemiologic data remain limited and inconsistent, falling short of establishing a clear causal relationship. Different classes of chemicals seem to push in different directions. In boys, for example, some polychlorinated biphenyls have been associated with accelerated puberty, while insecticides, organochlorine pesticides, and lead exposure have been linked to delayed puberty. In girls, results are similarly mixed across exposure types.

One prospective study looked specifically at prenatal and childhood exposure to chemical mixtures and the risk of early breast development at age eight. Maternal cadmium exposure during the second trimester was associated with higher risk, while prenatal BPA exposure was associated with lower risk. Childhood chemical exposures at age eight did not show significant associations with early breast development in that study. The takeaway is that the timing of exposure matters, that different chemicals can push puberty in opposite directions, and that we are still far from a neat cause-and-effect story.

When Puberty Falls Outside Normal Timing

One of the main clinical uses of Tanner staging is identifying children who are developing too early or too late. Precocious puberty is generally defined as the appearance of Stage 2 characteristics before age eight in girls or age nine in boys. Delayed puberty is typically flagged when there are no signs of Stage 2 by age thirteen in girls or fourteen in boys. Both can signal underlying conditions that need evaluation, from benign variants of normal to hormone-producing tumors or genetic syndromes. Tanner staging gives clinicians a common vocabulary to document what they see and track whether the pace of progression is appropriate. A child who leaps from Stage 2 to Stage 4 in a matter of months, for instance, would raise different concerns than one who progresses steadily over several years.

Bone age assessment often accompanies Tanner staging in clinical evaluations. In children with certain conditions, skeletal maturity can run ahead of chronological age. A study of children with myelomeningocele found that bone age was advanced relative to chronological age across puberty, with the largest gap, about 2.9 years, seen at Tanner Stage 5. Higher Tanner stage and higher body weight were the strongest predictors of that advancement. This kind of discrepancy matters practically: advanced bone age can mean less remaining growth potential than a child’s chronological age would suggest.

Tanner Staging in Gender-Affirming Care

Tanner stages play a specific gatekeeping role in the medical management of transgender and gender-diverse youth. Guidelines for puberty-suppressing medications, specifically GnRH agonists, stipulate that treatment can only begin after the adolescent has entered Tanner Stage 2. The rationale is partly diagnostic: experiencing the initial physical changes of puberty helps confirm that pubertal distress is persistent rather than prepubertal anxiety about growing up. A study of 438 transgender and gender-diverse youth found that those who received pubertal blockade at Tanner Stage 2 or 3 scored significantly lower on measures of internalizing problems, anxiety, and depression compared to those who had not received blockade. Tanner staging thus serves as both a clinical eligibility criterion and a timing reference point in this area of care.

Limitations Worth Knowing About

For all its usefulness, the Tanner scale has real blind spots. It was developed from a sample of British children of predominantly European descent, and patterns of pubertal development can differ across ethnic and geographic populations. Breast development staging can be confounded by body fat: in an overweight girl, it can be difficult to distinguish true glandular breast tissue at Stage 2 from adipose tissue, which can lead to overdiagnosis of early puberty. In boys, as noted, the earliest genital changes can be subtle enough that a nontrivial percentage of boys near the onset of puberty are misclassified by visual inspection alone.

The stages are also inherently categorical snapshots of what is really a continuous process. A child rated at Stage 3 today could be barely past Stage 2 or nearly at Stage 4, and the single number does not capture that. Hormone levels and the physical signs they produce can fall out of alignment as puberty progresses: one study of boys found that hormone measures and Tanner stage assessments were similar early in development but diverged later. And the two Tanner features tracked in each sex, breast versus pubic hair in girls, genitalia versus pubic hair in boys, are driven by somewhat different hormonal pathways and often progress at different rates in the same person. A single Tanner “stage” assigned to a child is a simplification. In practice, a thorough assessment will record separate ratings for each feature.

Despite these caveats, no replacement has gained traction. The Tanner scale endures because it provides a standardized, reproducible framework that does not require lab work or imaging. For most clinical purposes, including screening for timing abnormalities, monitoring treatment, and contextualizing growth and metabolic data, it remains good enough. The key is understanding what it measures, what it approximates, and where its edges get blurry.